Effect of nimotuzumab combined with gemcitabine and tegafur gimeracil oteracil potassium on the treatment of advanced pancreatic cancer and on expressions of E-cadherin and β-catenin in cancer tissue

Ma Yanrong; Zhao Li; Wang Yongzeng; Zhang Jing; Wang Lipeng; Li Weiyuan

doi:10.3760/j.issn.1673-4777.2021.10.011

Home>Articles>Effect of nimotuzumab combined with gemcitabine and tegafur gimeracil oteracil potassium on the treatment of advanced pancreatic cancer and on expressions of E-cadherin and β-catenin in cancer tissue

DOI: 10.3760/j.issn.1673-4777.2021.10.011

Effect of nimotuzumab combined with gemcitabine and tegafur gimeracil oteracil potassium on the treatment of advanced pancreatic cancer and on expressions of E-cadherin and β-catenin in cancer tissue

Ma Yanrong

Zhao Li

Wang Yongzeng

Zhang Jing

Wang Lipeng

Li Weiyuan

Machine-generated Keywords：

Publication Date：2021-10-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：5( 1480-1484 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2021,16(10)